📰 Front Immunol News
Front Immunol News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Front Immunol. Real-time updates on events, politics, business and more.
January 10, 2024
In this analysis, the investigators note that the clinical association may be helpful to be taken into account as clinicians treat patients with HS.
July 25, 2023
This article explores the importance of immunoprofiling in the context of diseases, inflammatory status, and immune fitness.
July 7, 2023
In this article, ACROBiosystems highlights a few immune system agonists and describe how they could aid in immunotherapy.
June 7, 2023
Real-world data and expert perspectives on state-of-the-art clinical practice for the management of infection in patients with CLL will be showcased during the Octapharma Update-in-Hematology session
March 8, 2023
A clinical look at the use of imaging technology for treating inflammatory disorders
February 24, 2023
This article outlines the powerful role of biomarkers in precision medicine, such as the use of autoantibodies for drug discovery against cancer.
May 20, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits variable immunity responses among hosts based on symptom severity. Whether immunity in recovered individuals is effective for avoiding reinfection is poorly understood. Determination of immune memory status against SARS-CoV-2 helps identify reinfection risk and vaccine efficacy. Hence, after recovery from COVID-19, evaluation of protective effectiveness and durable immunity of prior disease could be significant. Recent reports...
May 19, 2022
African swine fever (ASF) is among the most devastating viral diseases of pigs and wild boar worldwide. In recent years, the disease has spread alarmingly. Despite intensive research activities, a commercialized vaccine is still not available, and efficacious live attenuated vaccine candidates raise safety concerns. From a safety perspective, inactivated preparations would be most favourable. However, both historical and more recent trials with chemical inactivation did not show an appreciable p...
March 25, 2022
Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohns Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody ... | March 25, 2022